Farm-level factors associated with above-average production on pig farms in Evia, Greece.

The aim of this study was to identify farm-level factors associated with above-average production of pig farms in Evia, Greece. Cross-sectional data on pig farm characteristics and management, farmer characteristics, worming practices, anthelmintics used, and the parasite loads of 10 randomly selected boars, sows, weaners, and fatteners were collected from 28 pig enterprises in the Evian region of Greece (74% of the total number of pig enterprises in this region). Above-average productivity was defined as weaning 18 or more piglets per sow per year. A multivariate logistic regression model found that employing immigrant workers reduced the odds of a farm being an above-average producer (OR 0.016, 95% CI 0.001-0.27), while having a veterinarian select the anthelmintic strategy significantly increased the odds of a farm being an above-average producer (OR 10.24, 95% CI 0.78-135.13). None of the gastrointestinal parasites under investigation were significantly associated with above-average productivity. It is concluded that despite the fact that endoparasite load was not significantly associated with above-average production, a quantification of the impact of intestinal worms on pig productivity is needed to know how much control can be envisaged for gastrointestinal worms before reaching the threshold at which it is no longer physically or financially reasonable to continue pursuing control.

Cholestatic syndromes in renal transplant recipients with HCV infection.

We present two distinct types of cholestatic syndrome identified in eight renal transplant (RTx) patients with HCV infection. Four patients developed fibrosing cholestatic hepatitis (FCH) and four, vanishing bile duct syndrome (VBDS). All patients with FCH were anti-HCV (-) at the time of Tx and developed a cholestatic profile 1-4 months post-Tx, with high HCV-RNA levels. Immunosuppressive therapy was drastically reduced. Two patients died of sepsis and liver failure 16 and 18 months post-Tx, and the other two showed marked improvement and seroconverted to anti-HCV. Regarding the patients with VBDS, three were anti-HCV (-) and one was anti-HCV (+)/HBsAg (+) at the time of RTx. Two patients became anti-HCV (+) 1 year, and one patient, 3 years post-Tx. Two patients developed progressive VBDS and died of liver failure 2 and 3 years after onset, and two showed marked improvement after withdrawal of immunosuppression. In two of the patients, the progression of the disease coincided with elevation in serum HCV RNA levels. We concluded that a progressive cholestatic syndrome acquiring features of FCH or VBDS may develop in HCV-infected RTx patients. The association with high viral load implicated the virus in the pathogenesis. Drastic reduction of immunosuppression may favourably affect the outcome.